{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:56:12Z","timestamp":1791107772663,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2411,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/ki.2009.9","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T08:06:02Z","timestamp":1234944362000},"page":"936-944","source":"Crossref","is-referenced-by-count":99,"title":["Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt"],"prefix":"10.1016","volume":"75","author":[{"given":"William B.","family":"Lea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Soo","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Luther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes B.","family":"Fogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2009.9_bb0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/ki.2009.9_bb0015","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis","volume":"93","author":"Young","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.9_bb0020","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.9_bb0025","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.ATV.17.6.1152","article-title":"Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats","volume":"17","author":"Benetos","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/ki.2009.9_bb0030","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/ki.2009.9_bb0035","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.9_bb0040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1038\/ki.2009.9_bb0045","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury","volume":"37","author":"Fiebeler","year":"2007","journal-title":"Hypertension"},{"key":"10.1038\/ki.2009.9_bb0050","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1210\/en.2004-0005","article-title":"Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone\/salt-treated rats","volume":"145","author":"Young","year":"2004","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.9_bb0055","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/y05-068","article-title":"Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy","volume":"83","author":"Neves","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"issue":"Suppl N","key":"10.1038\/ki.2009.9_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/eurheartj\/16.suppl_N.103","article-title":"Aldosterone escape during ACE inhibitor therapy in chronic heart failure","volume":"16","author":"Struthers","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1038\/ki.2009.9_bb0065","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2009.9_bb0070","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1038\/ki.2009.9_bb0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjhyper.2004.06.029","article-title":"Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease","volume":"18","author":"Sato","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1038\/ki.2009.9_bb0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/en.2003-1137","article-title":"Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C","volume":"145","author":"Mihailidou","year":"2004","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.9_bb0085","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ Res"},{"key":"10.1038\/ki.2009.9_bb0090","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/01.RES.76.6.973","article-title":"Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells","volume":"76","author":"Wehling","year":"1995","journal-title":"Circ Res"},{"key":"10.1038\/ki.2009.9_bb0095","first-page":"E616","article-title":"Nongenomic effects of aldosterone on intracellular calcium in porcine endothelial cells","volume":"272","author":"Schneider","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2009.9_bb0100","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1210\/en.2002-220950","article-title":"Nongenomic effect of aldosterone on Na+,K+-adenosine triphosphatase in arterial vessels","volume":"144","author":"Alzamora","year":"2003","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.9_bb0105","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1161\/CIRCULATIONAHA.104.521625","article-title":"Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage","volume":"111","author":"Fiebeler","year":"2005","journal-title":"Circulation"},{"key":"10.1038\/ki.2009.9_bb0110","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.9_bb0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1210\/en.2007-0584","article-title":"Fadrozole reverses cardiac fibrosis in spontaneously hypertensive heart failure rats: discordant enantioselectivity versus reduction of plasma aldosterone","volume":"149","author":"Minnaard-Huiban","year":"2008","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.9_bb0120","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.HYP.37.2.801","article-title":"Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension","volume":"37","author":"Quaschning","year":"2001","journal-title":"Hypertension"},{"key":"10.1038\/ki.2009.9_bb0125","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1536\/ihj.47.783","article-title":"Combined treatment with valsartan and spironolactone prevents cardiovascular remodeling in renovascular hypertensive rats","volume":"47","author":"Okada","year":"2006","journal-title":"Int Heart J"},{"key":"10.1038\/ki.2009.9_bb0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0090-9556(25)06095-7","article-title":"Species differences in the metabolism and disposition of spironolactone","volume":"4","author":"Karim","year":"1976","journal-title":"Drug Metab Dispos"},{"key":"10.1038\/ki.2009.9_bb0135","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.HYP.0000182661.98259.4f","article-title":"Nongenomic effects of aldosterone in the human heart: interaction with angiotensin II","volume":"46","author":"Chai","year":"2005","journal-title":"Hypertension"},{"key":"10.1038\/ki.2009.9_bb0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/01.HYP.26.1.101","article-title":"Left ventricular fibrosis in renovascular hypertensive rats. Effect of losartan and spironolactone","volume":"26","author":"Nicoletti","year":"1995","journal-title":"Hypertension"},{"key":"10.1038\/ki.2009.9_bb0145","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0960-0760(03)00201-2","article-title":"Aldosterone regulation of T-type calcium channels","volume":"85","author":"Rossier","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1038\/ki.2009.9_bb0150","doi-asserted-by":"crossref","first-page":"7K","DOI":"10.1016\/0002-9149(90)91267-A","article-title":"Calcium channel antagonist effects of spironolactone, an aldosterone antagonist","volume":"65","author":"Mironneau","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1038\/ki.2009.9_bb0155","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1523-1755.2000.00277.x","article-title":"Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo","volume":"58","author":"Brown","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.9_bb0160","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/j.1523-1755.2004.00913.x","article-title":"Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats","volume":"66","author":"Fujisawa","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.9_bb0165","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/sj.ki.5000201","article-title":"Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury","volume":"69","author":"Ma","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.9_bb0170","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.CIR.0000097000.51723.6F","article-title":"Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II\/NG-nitro-L-arginine methyl ester-induced myocardial injury","volume":"108","author":"Oestreicher","year":"2003","journal-title":"Circulation"},{"key":"10.1038\/ki.2009.9_bb0175","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1161\/01.CIR.0000131860.80444.AB","article-title":"Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells","volume":"109","author":"Mazak","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/ki.2009.9_bb0180","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1523-1755.2000.00277.x","article-title":"Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo","volume":"58","author":"Brown","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.9_bb0185","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/sj.ki.5002268","article-title":"Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency","volume":"72","author":"Brown","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.9_bb0190","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.HYP.13.6.706","article-title":"Angiotensin II induces c-fos expression in smooth muscle via transcriptional control","volume":"13","author":"Naftilan","year":"1989","journal-title":"Hypertension"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815538283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815538283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:04:42Z","timestamp":1738940682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815538283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0085253815538283"],"URL":"https:\/\/doi.org\/10.1038\/ki.2009.9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1161553.623104","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}